Opdualag
(nivolumab / relatlimab)Opdualag 240 MG / 80 MG in 20 ML Injection
NO BLACK BOX WARNING
Dosage & administration
biomarker testing
Opdualag clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.
drug label
Opdualag prescribing information
financial assistance
Opdualag financial assistance options
Co-pay savings program
commercial only
Learn More
Foundation programs
under insured
no insurance
goverment insurance
65+
Learn More
patient education
Opdualag patient education
Getting started on Opdualag
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
Learn More
Other resources
Learn More
people also ask
Opdualag FAQs
How is the dosage of Opdualag?Opdualag is available in 1 dosages, including 12-4 mg/ml Injection 20 ml
What does Opdualag treat?Opdualag treats Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma, Kidney Neoplasms, Lymphoma and Melanoma
What is Opdualag made of?Opdualag contains nivolumab / relatlimab which is a Programmed Death Receptor-1 Blocking Antibody
How Is Opdualag Administered?Opdualag is administered as a Injectable
What Are The Opdualag Mechanism Of Action?Opdualag mechanism of action is Programmed Death Receptor-1-directed Antibody Interactions
FAQ Data Source